A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma
PHASE1
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer
PHASE1
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth
N/A
The investigators will develop a radiomics signature for immune checkpoint-...